Therefore, in our most recent studies we investigated whether serum CXCL-8 and its specific receptor (CXCR-2) may be used as potential biochemical tumor markers for CRC using the enzyme-linked immunosorbent assays (ELISA) method. The gene discussed is CXCL8; the disease is neoplasm.